CONMED CORP

Explore CONMED’s latest stock performance and high P/E ratio, and learn how the orthopedic‑equipment maker can boost innovation, cut costs, and win back investors.

Explore CONMED Corp’s 2025 results and 2026 outlook: steady revenue growth, margin pressure, and strategic focus on minimally invasive surgery for future gains.

Conmed Corp’s Q1 2025 financial performance was marked by robust earnings growth and strategic advancements, despite supply chain challenges and international sales declines, positioning the company for future growth.